Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The purpose of this study was to examine the behavioral effects of four doses of psychostimulant medication, combining extended-release methylphenidate (MPH) in the morning with immediate-release MPH in the afternoon. METHOD: The sample comprised 24 children (19 boys; 5 girls) who met American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV-TR) criteria for an autism spectrum disorder (ASD) on the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS), and had significant symptoms of attention-deficit/hyperactivity disorder (ADHD). This sample consisted of elementary school-age, community-based children (mean chronological age=8.8 years, SD=1.7; mean intelligence quotient [IQ]=85; SD=16.8). Effects of four dose levels of MPH on parent and teacher behavioral ratings were investigated using a within-subject, crossover, placebo-controlled design. RESULTS: MPH treatment was associated with significant declines in hyperactive and impulsive behavior at both home and school. Parents noted significant declines in inattentive and oppositional behavior, and improvements in social skills. No exacerbation of stereotypies was noted, and side effects were similar to those seen in typically developing children with ADHD. Dose response was primarily linear in the dose range studied. CONCLUSIONS: The results of this study suggest that MPH formulations are efficacious and well-tolerated for children with ASD and significant ADHD symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318179964f · Cited by 3,399
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
A critical review of visual analogue scales in the measurement of clinical phenomena
Wewers, M. E., & Lowe, N. K. (1990) · Research in Nursing & Health · doi:10.1002/nur.4770130405 · Cited by 2,580 · cited 1×
“Visual Analog Scale (VAS; Wewers & Lowe 1990).”
MethodPliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Comorbid psychiatric disorders in children with autism: interview development and rates of disorders
Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., Tager-Flusberg, H., & Lainhart, J. E. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0123-0 · Cited by 1,637 · cited 2×
“Indeed, 14–75% of children with ASD are reported to have symptoms of inattention, hyperactivity, and impulsivity severe enough to warrant a diagnosis of attention- deficit/hyperactivity disorder (ADHD) (Frazier et al. 2001; Goldstein and Schwebach 2004; Sturm et al. 2004; Lecavalier 2006; Leyfer et al. 2006; Pearson e…”
BackgroundVarieties of Repetitive Behavior in Autism: Comparisons to Mental Retardation
Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M. H. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005596502855 · Cited by 1,223 · cited 2×
“Future investigations using more comprehensive measures of repetitive and stereotyped behaviors (e.g., the Repetitive Behavior Scale-Revised, Bodfish et al. 2000; Children’s Yale-Brown Obsessive Compulsive Scale [CY-BOCS]-PDD, Scahill et al. 2006) across multiple settings/raters are needed to…”
BackgroundMolina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182
Self-citationLecavalier, L. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0147-5 · Cited by 569 · cited 2×
“Indeed, 14–75% of children with ASD are reported to have symptoms of inattention, hyperactivity, and impulsivity severe enough to warrant a diagnosis of attention- deficit/hyperactivity disorder (ADHD) (Frazier et al. 2001; Goldstein and Schwebach 2004; Sturm et al. 2004; Lecavalier 2006; Leyfer et al. 2006; Pearson e…”
Background(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475
Self-citationSprague, R. L., & Sleator, E. K. (1977) · Science · doi:10.1126/science.337493 · Cited by 441 · cited 1×
“Although such findings suggest that higher doses of carefully monitored stimulant treatment are associated with better outcomes, others (e.g., Sprague and Sleator 1977; Gan and Cantwell 1982) have reported a curvilinear response to stimulant medication: lower doses produced initial improvements…”
BackgroundGoldstein, S., & Schwebach, A. J. (2004) · Journal of Autism and Developmental Disorders · doi:10.1023/b:jadd.0000029554.46570.68 · Cited by 412 · cited 2×
“…hyperactivity, and impulsivity severe enough to warrant a diagnosis of attention- deficit/hyperactivity disorder (ADHD) (Frazier et al. 2001; Goldstein and Schwebach 2004; Sturm et al. 2004; Lecavalier 2006; Leyfer et al. 2006; Pearson et al. 2006; Reiersen et al. 2007; Simonoff et al.…”
BackgroundAutistic traits in a population-based ADHD twin sample
Reiersen, A. M., Constantino, J. N., Volk, H. E., & Todd, R. D. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01720.x · Cited by 352 · cited 2×
“Indeed, 14–75% of children with ASD are reported to have symptoms of inattention, hyperactivity, and impulsivity severe enough to warrant a diagnosis of attention- deficit/hyperactivity disorder (ADHD) (Frazier et al. 2001; Goldstein and Schwebach 2004; Sturm et al. 2004; Lecavalier 2006; Leyfer et al. 2006; Pearson e…”
BackgroundGREENHILL, L. L., SWANSON, J. M., VITIELLO, B., DAVIES, M., CLEVENGER, W., WU, M., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00012 · Cited by 287
Self-citationNeurofunctional mechanisms in autism
Waterhouse, L., Fein, D., & Modahl, C. (1996) · Psychological Review · doi:10.1037/0033-295x.103.3.457 · Cited by 218
The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up
Riddle, M. A., Yershova, K., Lazzaretto, D., Paykina, N., Yenokyan, G., Greenhill, L., Abikoff, H., Vitiello, B., Wigal, T., McCracken, J. T., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.007 · Cited by 202
Sturm, H., Fernell, E., & Gillberg, C. (2004) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2004.tb00503.x · Cited by 186 · cited 2×
“Indeed, 14–75% of children with ASD are reported to have symptoms of inattention, hyperactivity, and impulsivity severe enough to warrant a diagnosis of attention- deficit/hyperactivity disorder (ADHD) (Frazier et al. 2001; Goldstein and Schwebach 2004; Sturm et al. 2004; Lecavalier 2006; Leyfer et al. 2006; Pearson e…”
BackgroundMedication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences
Aman, M. G., Lam, K. S. L., & Van Bourgondien, M. E. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.116 · Cited by 174
Self-citationJahromi, L. B., Kasari, C. L., McCracken, J. T., Lee, L. S.-Y., Aman, M. G., McDougle, C. J., Scahill, L., Tierney, E., Eugene Arnold, L., Vitiello, B., et al. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0636-9 · Cited by 144
Self-citationPosey, D. J., Aman, M. G., McCracken, J. T., Scahill, L., Tierney, E., Arnold, L. E., Vitiello, B., Chuang, S. Z., Davies, M., Ramadan, Y., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.028 · Cited by 131
Self-citationSantosh, P. J., Baird, G., Pityaratstian, N., Tavare, E., & Gringras, P. (2006) · Child: Care, Health and Development · doi:10.1111/j.1365-2214.2006.00631.x · Cited by 123 · cited 5×
“Although this emerging literature is encouraging, stimulants have also been associated with some undesirable symptoms, including insomnia (Birmaher et al. 1988; RUPP Autism Network 2005; Santosh et al. 2006), loss of appetite (Quintana et al.”
BackgroundResultInfluentialFrazier, T. W., Shattuck, P. T., Narendorf, S. C., Cooper, B. P., Wagner, M., & Spitznagel, E. L. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0057 · Cited by 113 · cited 2×
“Recent reports have suggested that the majority of children with ASD are being treated with psychotropic medication, including 58% of children with ASD and ADHD symptoms (Frazier et al. 2011; Pringle et al. 2012).”
BackgroundDi Martino, A., Melis, G., Cianchetti, C., & Zuddas, A. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649011 · Cited by 82 · cited 7×
“However, stimulant response is rapid, and as DiMartino et al. (2004) noted, children who did not show adverse effects of MPH in a single dose also did not demonstrate adverse effects in a 3 month trial.”
BackgroundInfluential
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Volkmar, F., Siegel, M., Woodbury-Smith, M., King, B., McCracken, J., & State, M. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.10.013 · Cited by 848
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
An update on the comorbidity of ADHD and ASD: a focus on clinical management
Antshel, K. M., Zhang-James, Y., Wagner, K. E., Ledesma, A., & Faraone, S. V. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1146591 · Cited by 262
Metadata
- Authors
- Pearson, D. A., Santos, C. W., Aman, M. G., Arnold, L. E., Casat, C. D., Mansour, R., Lane, D. M., Loveland, K. A., Bukstein, O. G., Jerger, S. W., Factor, P., Vanwoerden, S., Perez, E., & Cleveland, L. A.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-06
- Volume
- 23
- Issue
- 5
- Pages
- 337-351
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2061313353
- Cited by
- 108
- References
- 23
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.